ChemComm
Communication
Table 1 Potentials of NNO2 reduction in different sequence contexts
Ea/V
potential is relatively low (max. 10 mV differences). These data
support our on-going project of multi-potential redox labelling
for electrochemical detection.3c,d
Ea/V
AAA
CAA
CAC
CAT
GAA
GAC
GAG
GAT
TAA
TAT
ꢀ0.505
ꢀ0.505
ꢀ0.505
ꢀ0.505
ꢀ0.500
ꢀ0.490
ꢀ0.485
ꢀ0.485
ꢀ0.500
ꢀ0.490
TUC
GUC
GUA
TCT
GCT
GCA
TGC
GGC
GGA
ꢀ0.510
ꢀ0.515
ꢀ0.505
ꢀ0.495
ꢀ0.510
ꢀ0.515
ꢀ0.510
ꢀ0.515
ꢀ0.505
This work was supported by the Academy of Sciences of the
Czech Republic (RVO: 61388963 and 68081707) and by the
Czech Science Foundation (P206-12-G151).
Notes and references
1 (a) M. Hocek and M. Fojta, Org. Biomol. Chem., 2008, 6, 2233–2241;
¨
(b) S. Jager, G. Rasched, H. Kornreich-Leshem, M. Engeser, O. Thum
and M. Famulok, J. Am. Chem. Soc., 2005, 127, 15071–15082;
a
Peak potentials at the hanging mercury drop electrode against
Ag|AgCl|3 M KCl. The nitrophenyl-modified bases are always in the
center of the triplet (in bold); other parts of the ONs outside these
triplets are identical in all of them (see ON1–ON23 sequences in Table S1).
For more details see the ESI.
ˇ
´
(c) P. Capek, H. Cahova, R. Pohl, M. Hocek, C. Gloeckner and
A. Marx, Chem.–Eur. J., 2007, 13, 6196–6203.
2 (a) L. H. Thoresen, G.-S. Jiao, W. C. Haaland, M. L. Metzker and
K. Burgess, Chem.–Eur. J., 2003, 9, 4603–4610; (b) J. Riedl, R. Pohl,
´ˇ
L. Rulısek and M. Hocek, J. Org. Chem., 2012, 77, 1026–1044;
(c) J. Riedl, R. Pohl, N. P. Ernsting, P. Orsag, M. Fojta and
´
´
M. Hocek, Chem. Sci., 2012, 3, 2797–2806; (d) J. Riedl, P. Menova,
depended to some extent on both the conjugate nucleobases
and the sequence context. However, especially variations in the
peak potentials reflecting changes in the sequence context were
relatively small, in most cases at the preciseness limit of the
reference electrode and the instrument setup (5–10 mV).
It seems that the presence of thymine and/or guanine next to
the modification site had the most pronounced effect on the
peak potential, shifting the nitro group reduction to less
negative values (Table 1).
In conclusion, we have developed the first general method-
ology for enzymatic synthesis of ssONs bearing a single base-
modification in the internal part of the sequence. A simple and
facile SNI-PEX (+magnetoseparation) procedure is applicable to
all sequences when the modification is followed by another
nucleobase. If the modification needs to be incorporated into a
homonucleobase stretch, the SNI is performed using a bio-
tinylated template one-nucleotide longer than the primer and
after the magnetoseparation the extended primer is subjected
to another PEX with a full-length template. This procedure is
more laborious but is generally applicable to any sequence.
This novel methodology enables for the first time preparation
of ssON probes bearing one site specific single modification
(i.e. redox or other label) at one nucleobase using enzymatic
synthesis. The only limitation is that the dNXTP must be a good
substrate for DNA polymerase. The approach is likely to find
broad applications in the construction of diverse base-modified
ON probes. We have demonstrated its utility by the synthesis of
different labelled sequences (containing one dNNO2 nucleotide)
which showed that the influence of the sequence on the redox
´
R. Pohl, P. Orsag, M. Fojta and M. Hocek, J. Org. Chem., 2012, 77,
8287–8293.
´
´
´
ˇ
´
3 (a) P. Brazdilova, M. Vrabel, R. Pohl, H. Pivonkova, L. Havran,
M. Hocek and M. Fojta, Chem.–Eur. J., 2007, 13, 9527–9533;
(b) H. Cahova, L. Havran, P. Brazdilova, H. Pivonkova, R. Pohl,
M. Fojta and M. Hocek, Angew. Chem., Int. Ed., 2008, 47, 2059–2062;
(c) M. Vrabel, P. Horakova, H. Pivonkova, L. Kalachova, H. Cernocka,
H. Cahova, R. Pohl, P. Sebest, L. Havran, M. Hocek and M. Fojta,
Chem.–Eur. J., 2009, 15, 1144–1154; (d) J. Balintova, R. Pohl,
P. Horakova, P. Vidlakova, L. Havran, M. Fojta and M. Hocek,
Chem.–Eur. J., 2011, 17, 14063–14073; (e) V. Raindlova, R. Pohl,
´
´
´
ˇ
´
ˇ
´
´
´
´
ˇ
ˇ
´
´
´
´
´
´
´
´
ˇ
´ˇ
´
´
´
´
ˇ
´
B. Klepetarova, L. Havran, E. Simkova, P. Horakova, H. Pivonkova,
M. Fojta and M. Hocek, ChemPlusChem, 2012, 77, 652–662; ( f ) D. A.
Di Giusto, W. A. Wlassoff, S. Geisebrecht, J. J. Gooding and G. C. King,
J. Am. Chem. Soc., 2004, 126, 4120–4121; (g) D. A. Di Giusto,
W. A. Wlassoff, S. Geisebrecht, J. J. Gooding and G. C. King, Angew.
Chem., Int. Ed., 2004, 43, 2809–2812; (h) W. A. Wlassoff and G. C. King,
Nucleic Acids Res., 2002, 30, e58; (i) S. S. W. Yeung, T. M. H. Lee and
I.-M. Hsing, J. Am. Chem. Soc., 2006, 128, 13374–13375; ( j) H. Weizman
and Y. Tor, J. Am. Chem. Soc., 2002, 124, 1568–1569.
4 S. Obeid, M. Yulikow, G. Jeschke and A. Marx, Angew. Chem., Int. Ed.,
2008, 47, 6782–6785.
5 A. Baccaro, A.-L. Steck and A. Marx, Angew. Chem., Int. Ed., 2012, 51,
254–257.
6 (a) V. Borsenberger, M. Kukwikila and S. Howorka, Org. Biomol.
Chem., 2009, 7, 3826–3835; (b) C. T. Wirges, J. Timper, M. Fischler,
A. S. Sologubenko, J. Mayer, U. Simon and T. Carell, Angew. Chem.,
ˇ
´
Int. Ed., 2009, 48, 219–223; (c) V. Raindlova, R. Pohl, M. Sanda and
M. Hocek, Angew. Chem., Int. Ed., 2010, 49, 1064–1066; (d) V. Raindlova,
´
R. Pohl and M. Hocek, Chem.–Eur. J., 2012, 18, 4080–4087.
´ˇ
´
´
´ˇ
7 (a) H. Macıckova-Cahova and M. Hocek, Nucleic Acids Res., 2009, 37,
7612–7622; (b) H. Macıckova-Cahova, R. Pohl and M. Hocek, Chem-
BioChem, 2011, 12, 431–438; (c) P. Kielkowski, H. Macıckova-Cahova,
R. Pohl and M. Hocek, Angew. Chem., Int. Ed., 2011, 50, 8727–8730.
´
´
´ˇ
´
´
´
´
8 P. Menova and M. Hocek, Chem. Commun., 2012, 48, 6921–6923.
ˇ
´
´
´ˇ
´
´
ˇ
´
ˇ
9 P. Horakova, H. Macıckova-Cahova, H. Pivonkova, J. Spacek,
L. Havran, M. Hocek and M. Fojta, Org. Biomol. Chem., 2011, 9,
1366–1371.
c
4654 Chem. Commun., 2013, 49, 4652--4654
This journal is The Royal Society of Chemistry 2013